← Back to Clinical Trials
Recruiting NCT02548546

NCT02548546 Estimation of Biomechanical Aortic Wall Properties in Healthy and Aneurysmal Aortas Using Novel Imaging Techniques

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT02548546
Status Recruiting
Phase
Sponsor Mayo Clinic
Condition Abdominal Aortic Aneurysm
Study Type INTERVENTIONAL
Enrollment 30 participants
Start Date 2015-08
Primary Completion 2026-08

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
ECHOECG-gated MRA

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 30 participants in total. It began in 2015-08 with a primary completion date of 2026-08.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The primary aim of this study is to establish the practicality of using two novel imaging modalities for the assessment of biomechanical properties of the aorta.

Eligibility Criteria

Inclusion Criteria: * Patients \>18 years of age with ability to provide informed consent. * Patients with either symptomatic or asymptomatic AAA as defined by aortic diameter ≥ 1.5x normal diameter. * Patients with non-aneurysmal aortas who require aortic contrast imaging or echocardiography for preoperative planning or other reason. Exclusion Criteria: * Patients with contraindication to IV contrast such as allergy or severe kidney dysfunction. * Patients who do not require contrast imaging or echocardiogram as part of their care plan. * Terminally ill patients, and patients with estimated life expectancy of ≤ 6 months. * Patients unable to tolerate magnetic resonance imaging.

Contact & Investigator

Central Contact

Houssam Farres, MD

✉ farres.houssam@mayo.edu

📞 904-953-2077

Principal Investigator

Houssam Farres, MD

PRINCIPAL INVESTIGATOR

Mayo Clinic

Frequently Asked Questions

Who can join the NCT02548546 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Abdominal Aortic Aneurysm. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT02548546 currently recruiting?

Yes, NCT02548546 is actively recruiting participants. Contact the research team at farres.houssam@mayo.edu for enrollment information.

Where is the NCT02548546 trial being conducted?

This trial is being conducted at Jacksonville, United States.

Who is sponsoring the NCT02548546 clinical trial?

NCT02548546 is sponsored by Mayo Clinic. The principal investigator is Houssam Farres, MD at Mayo Clinic. The trial plans to enroll 30 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology